Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

Minocycline EP Impurity G

● Auf Lager

Katalog-Nr.::	VE0017091
CAS-Nr.::	N/A
Summenformel::	C25H33ClN4O7
Molare Masse::	537.01 g/mol

Angebot anfordern

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu Minocycline EP Impurity G

Parent drug

Minocycline

IUPAC-Name

(4S, 4aS, 5aR, 12aS)-4, 7, 9-Tris(dimethylamino)-3, 10, 12, 12a-tetrahydroxy-1, 11-dioxo-1, 4, 4a, 5, 5a, 6, 11, 12a-octahydrotetracene-2-carboxamide hydrochloride

Pharmakopöe-Synonyme

N/A

Other Synonyms

9-Dimethylamino Minocycline Hydrochloride/ Minocycline 4,7,9-Tris-Dimethylamino Impurity Hydrochloride

SMILES

O=C(C1=C(O)[C@@H](N(C)C)[C@@](C[C@@]2([H])C(C(C3=C(O)C(N(C)C)=CC(N(C)C)=C3C2)=O)=C4O)([H])[C@@]4(O)C1=O)N.[H]Cl

Inchl

InChI=1S/C25H32N4O7.ClH/c1-27(2)13-9-14(28(3)4)19(30)16-11(13)7-10-8-12-18(29(5)6)21(32)17(24(26)35)23(34)25(12,36)22(33)15(10)20(16)31;/h9-10,12,18,30,32-33,36H,7-8H2,1-6H3,(H2,26,35);1H/t10-,12-,18-,25-;/m0./s1

Beschreibung

The compound Minocycline EP Impurity G is a highly characterized reference material that meets stringent regulatory standards, including those set by USP, EMA, JP, and BP. This product is essential for a variety of applications, such as analytical method development, method validation (AMV), and Quality Control (QC), particularly in the context of Minocycline production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). Additionally, the product comes with a detailed Structure Elucidation Report (SER), ensuring its precision and reliability for comprehensive analytical use.